Stay updated on Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange Detected- Added a government-operating-status notice and linked details (cc.nih.gov, opm.gov). - Updated version to v3.2.0. - Removed the resource entry for Genetic and Rare Diseases Information Center: Small cell lung carcinoma and the older v3.1.0 version tag.SummaryDifference4%
- Check17 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element has been removed.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while also removing various related topics and specific terms associated with lung cancer treatment.SummaryDifference4%
- Check60 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegzilarginase and Pembrolizumab in Small Cell Lung Cancer Clinical Trial page.